{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Return to MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center
  • Sign In
  • Home
  • Live
  • On-Demand
  • RSS/Grand Rounds
  • Non-Accredited
  • About
  • Contact Us
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

MD Anderson workforce members:  Select "MD ANDERSON LOGIN" and enter your MD Anderson email address and password.

Guests (all other than MD Anderson workforce members): Select "GUEST LOGIN" and enter your email address and password.

MD ANDERSON LOGIN
GUEST LOGIN
Enter your email and password to login:

*
*
Login

New to CloudCME? Create an Account:

Create New Account
Back to Login Provider Forgot Your Password?

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Email is required Invalid: Enter valid email address
First Name is required
Last Name is required
Password is required


Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =
Confirm password

Passwords must match
Password must be between 8 and 16 characters and contain the following:
•at least 1 upper case character
•at least 1 lower case character
•at least 1 numerical character
•at least 1 special character

  • -- Select Degree --
  • AA
  • AAS
  • ADN
  • BA
  • BS
  • BSN
  • DDS
  • DMD
  • DMin
  • DNP
  • DO
  • DrPH
  • DVM
  • DVM,PhD
  • EdD
  • JD
  • MA
  • MBA
  • MBBS
  • MBBS,MD
  • MD
  • MD, MBA
  • MD, MPH
  • MD, PhD
  • MDiv
  • MEd
  • MHA
  • MPA
  • MPH
  • MS
  • MSN
  • MSW
  • None
  • Other
  • PharmD
  • PharmD, PhD
  • PhD
  • PsyD
Degree is required
Please enter your degree:
You must enter a degree

Profession is required




Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.

please enter a term to search
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

Updates in Advanced Breast Cancer: Local Management and Other New Perspectives


LIVE
Updates in Advanced Breast Cancer: Local Management and Other New Perspectives Banner

  • Overview
  • Faculty
  • Schedule
  • Brochure
  • Hotel
  • Exhibitors
  • Register
Add to Calendar Updates in Advanced Breast Cancer: Local Management and Other New Perspectives 2/28/2025 7:00:00 AM 3/1/2025 1:00:00 PM America/Chicago For More Details: https://mdanderson.cloud-cme.com/ABC2025 Description: This educational event is here to help oncologists and healthcare providers stay on the cutting edge of advanced breast cancer care. We aim to make it easier for you to bring the latest therapies and techniques into your everyday practice. The conference dives deep into the changing world of breast cancer treatment, focusing on the latest updates for triple-negative, inflammatory, locally advanced, and metastatic breast ... Marriott Medical Center Hotel Houston false MM/DD/YYYY


Date & Location
Friday, February 28, 2025, 7:00 AM - Saturday, March 1, 2025, 1:00 PM, Marriott Medical Center Hotel Houston, Houston, TX

Target Audience
Specialties - Medical Oncology
Professions - Counselor, Nurse - APRN, Nurse - LVN, Nurse - RN, Other, Pharmacist, Physician (MD or DO), Physician Associate, Social Worker, Student or Trainee

Credits
AMA PRA Category 1 Credits™ (10.50 hours), AAPA Category 1 CME (10.50 hours), ABIM MOC Part 2 (10.50 hours), ACPE Contact Hour(s) (10.50 hours), ANCC - Nursing Contact Hour(s) (10.50 hours), Non-Physician Attendance (10.50 hours), SW - Social Work (1.00 hours)

Overview

This educational event is here to help oncologists and healthcare providers stay on the cutting edge of advanced breast cancer care. We aim to make it easier for you to bring the latest therapies and techniques into your everyday practice. The conference dives deep into the changing world of breast cancer treatment, focusing on the latest updates for triple-negative, inflammatory, locally advanced, and metastatic breast cancers.

Our team of experts, including specialists from MD Anderson and beyond, will show you the power of working together as a multidisciplinary team. You'll learn how to identify specific genetic and protein markers linked to breast cancer. Through real-world discussions and case studies, you'll gain practical insights into providing top-notch, patient-centered care.

We'll also spotlight ongoing clinical trials that offer new hope for treating advanced, rare, and aggressive breast cancers. Our goal is to give you the tools to improve diagnostic accuracy, tailor treatments to each patient's unique cancer profile, assess how well treatments are working, and know when to refer patients to clinical trials.

By joining this activity, you'll not only keep up with the latest advancements but also develop the skills needed to navigate the complex world of breast cancer care. This knowledge is essential for making informed decisions that can significantly improve patient outcomes and push breast cancer treatment forward.


Objectives
At the conclusion of this activity, learners will be able to:

  1. Implement strategies to enhance physician-to-physician communication about the clinical trial process and its benefits, facilitating increased patient referrals and promoting a research-oriented culture in breast cancer care.
  2. Utilize interactive, personalized web-based clinical decision tools to optimize treatment selection for metastatic breast cancer patients.
  3. Integrate updated knowledge on new biological findings and genomic information into the clinical translation process, enhancing their ability to provide personalized and evidence-based care in their practice.
  4. Identify the key components of an effective multidisciplinary care approach in breast cancer management, including team composition, collaborative processes, and their impact on patient outcomes.
  5. Discuss the proficiency in applying evidence-based strategies for the diagnosis and multidisciplinary treatment of locally advanced and recurrent breast cancer, including surgery, radiation, and systemic therapies.

Registration

This one and a half day conference on Updates on Advanced Breast Cancer: Local Management and other New Perspectives will begin on Friday, Feb. 28, 2025, with Opening Remarks at 8:00 AM and will adjourn for the day at 6:00 PM.  The conference will reconvene on Saturday, Mar. 1, 2025 at 7:50 AM and adjourn at 1:00 PM.   This conference will be held at the Marriott Medical Center Hotel Houston, 6580 Fannin Street, Houston TX 77030. 

Advanced registration is encouraged as space is limited. If you are considering attending this conference, please follow the link below to create a profile in PEP prior to registering: https://mdanderson.cloud-cme.com/default.aspx

The deadline for advanced registration is Thursday, Jan. 30, 2025.

 

CONFERENCE REGISTRATION FEES:

Physicians (MDACC, TMC Members)

Postmarked before January 30, 2025

$80.00

Postmarked after January 30, 2025

$90.00

Physicians (Non-TMC Members, Non-MDACC)

Postmarked before January 30, 2025

$100.00

Postmarked after January 30, 2025

$125.00

Healthcare Professionals

Postmarked before January 30, 2025

$60.00

Postmarked after January 30, 2025

$75.00

Patients, Caregivers, Advocates, and Volunteers

Postmarked before January 30, 2025

$0

Postmarked after January 30, 2025

$0

Students/Trainees

Postmarked before January 30, 2025

$30.00

Postmarked after January 30, 2025

$30.00

We accept the following forms of payment:

  • Credit Cards (MasterCard, VISA, and American Express)

  • Check made payable to: The University of Texas MD Anderson Cancer Center (payable through U.S. banks only)

Mail to: 
Continuing Professional Education – Unit 1781
The University of Texas MD Anderson Cancer Center
 P.O. Box 301407
 Houston, Texas 77230-1407
Telephone registrations are not accepted

When registering online a receipt (confirmation) will be automatically emailed to the e-mail address you list on the registration form.

Refund/Cancellation Policy The registration fee, minus a $15.00 administration-handling fee, is refundable if a written request is received on or before Thursday, Jan. 30, 2025.  No refunds will be granted after these dates. The request for a registration refund must include the tax identification number of the company or institution if registration was paid by a company or institution check.
The Department of Continuing Professional Education (CPE), reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary.  Each registrant will be notified by mail, e-mail, or at the phone or fax numbers given on the registration form.  In case of activity cancellation, the liability of CPE, is limited to the registration fee.  CPE, will refund the full registration fee. 
CPE reserves the right to limit the number of participants in a program and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available. 
For additional information, contact CPE, at 713-792-2223 or toll free at 866-849-5866 or via e-mail: [email protected].
Special Assistance Contact CPE, at 713-792-2223 or toll free at 866-849-5866 if you have any ADA accommodation needs.


Accreditation

In support of improving patient care, The University of Texas MD Anderson Cancer Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Designation
The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 10.50 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The University of Texas MD Anderson Cancer Center designates this live activity will award 10.50 Nursing Contact Hour(s)Credit Designation



The University of Texas MD Anderson Cancer Center has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 10.50 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

The University of Texas MD Anderson Cancer Center designates this application-based activity for 10.50 hours under UAN JA0004118-0000-25-001-L99-P. Credits will be provided to NABP CPE Monitor within 60 days after the activity completion. Learners must provide their NABP e-profile ID and Date of Birth in their MyCE Profile for credits to be reported to CPE Monitor.

The University of Texas MD Anderson (CEU Provider #4607) is an approved continuing education provider for Social Workers through the Texas State Board of Social Worker Examiners. This activity has been approved for 1.00 continuing education units.


Additional Information

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.

 


You are not logged in.

Please click the button below to login or create a new account before continuing.

Login or Create Account

Accommodations
A block of rooms has been reserved for conference attendees at the Houston Marriott Medical Center Hotel, 6580 Fannin Street, Houston, Texas 77030

Start Date: Thursday, Feb. 27, 2025
End Date: Saturday, Mar. 1, 2025

Early hotel reservation is suggested; the group rate is offered through Mar. 1, 2025. The hotel phone number is 713-796-0080.

When you make reservations, be sure to mention the MD Anderson Advanced Breast Cancer Conference or Group Code: ABCABCR!  to be assured of receiving the special meeting rate of $199.00 USD per night. Reservations and deposits received after Jan. 30, 2025, will be confirmed if space is available and at currently published hotel guest room rates.

You can also use the registration link to receive the group rate: Book your group rate for MD Anderson Advanced Breast Cancer Conference Room Block

Click here for Reservation Link





The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.



Mitigation of Relevant Financial Relationships


The University of Texas MD Anderson Cancer Center adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Member Information
Role in activity
Nature of Relationship(s) / Name of Ineligible Company(s)
Eric Gagneaux
Continuing Education Planner
MD Anderson Cancer Center
Activity Administrator
Nothing to disclose
chunru lin, PhD
Associate Professor
MD Anderson Cancer
Co-Director, Faculty
Nothing to disclose
Bora Lim, MD
Associate Professor
MD Anderson Cancer Center
Course Director, Faculty
Membership on Advisory Committees or Review Panels, Board Membership, etc.-Gilead Sciences, Inc. (Relationship has ended)
Taiwo Adesoye, MD
MD ANDERSON CANCER CENTER
Faculty
Consulting Fee-Boehringer laboratories (Relationship has ended)
Moran Amit, MD, PhD
MD Anderson Cancer Center
Faculty
Nothing to disclose
Ashley Anderson, MSN, WHNP, CBCN
Advanced Practice Provider
MDACC
Faculty
Nothing to disclose
Isaac Chan, MD, PhD
UT Southwestern
Faculty
Nothing to disclose
Yaoyi Dai, MS
University of Texas, MD Anderson Cancer Center
Faculty
Nothing to disclose
Chelain Goodman, MD, PhD
Assistant Professor
UT MD Anderson Cancer Center
Faculty
Nothing to disclose
Rosemary Herron
Faculty
Nothing to disclose
Alice L Hughes, MPAS
MD Anderson Cancer Center
Faculty
Nothing to disclose
Abbey J Kaler, MS
Advanced Prac Registered Nurse, Breast Medical Oncology
The University of Texas MD Anderson Cancer Center
Faculty
Nothing to disclose
Wenbo Li, PhD
Associate Professor
UTHealth Houston
Faculty
Nothing to disclose
Julia Maués
GRASP
Faculty
Nothing to disclose
Victoria McClosky, BSN
Nursing Professional Development Specialist – Goal Concordant Care
MD Anderson Cancer Center
Faculty
Nothing to disclose
Melissa Mitchell, MD, PhD
Associate Professor
MD Anderson Cancer Center
Faculty
Grant or research support-ARTIDIS
Giancarlo Moscol, MD
Associate Professor
MDACC
Faculty
Membership on Advisory Committees or Review Panels, Board Membership, etc.-AstraZeneca US|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Novartis Pharmaceuticals Corporation
Jason A Mouabbi, MD
Assistant Professor
MD Anderson Cancer Center
Faculty
Consulting Fee-GE Healthcare|Honoraria-Cardinal Health (Relationship has ended)|Honoraria-Aptitude Health|Honoraria-BostonGene|Consulting Fee-AstraZeneca US|Honoraria-Gilead Sciences, Inc.|Honoraria-Novartis Pharmaceuticals Corporation
Oluchi Oke, MD
MD Anderson Cancer Center
Faculty
Nothing to disclose
Hind Rafei, MD MS
Fellow, Cancer Med - Fellowship Prog
MD Anderson Cancer Center
Faculty
Nothing to disclose
Hila Shaim, MD
MD Anderson Cancer Center
Faculty
Nothing to disclose
Wang Shein, BS
Unicorn Cancer Thrivers
Faculty
Nothing to disclose
Jasmine Sukumar, MD
University of Texas MD Anderson Cancer Center
Faculty
Nothing to disclose
Aatish Thennavan, PhD
Postdoctoral Fellow
MD Anderson Cancer Center
Faculty
Nothing to disclose
Ranjan Upadhyay, MD, PhD
MD Anderson Cancer Center
Faculty
Nothing to disclose
Steven Van Laere, PhD
Professor
Antwerp University
Belgium
Faculty
Nothing to disclose
Han Xiao, PhD
Rice Univ
Faculty
Nothing to disclose
Ying Yuan, PhD
Professor
University of Texas MD Anderson Cancer Center
Faculty
Consulting Fee-Amgen Inc.|Consulting Fee-AbbVie Inc.|Consulting Fee-Vertex|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Blueprint Medicines Corporation|Consulting Fee-Bristol-Myers Squibb Company|Consulting Fee-Ascendis|Consulting Fee-Century Tx|Consulting Fee-Boehringer Ingelheim|Consulting Fee-Repare|Consulting Fee-Servier Pharmaceuticals|Consulting Fee-Enliven|Consulting Fee-NGM Biopharm|Consulting Fee-Starpax|Consulting Fee-NeoImmuneTech|Consulting Fee-A2 Therapeutic|Consulting Fee-Bexion|Consulting Fee-Sangamo|Consulting Fee-GT Tech|Consulting Fee-Sumitomo
Larry W Coffer II II, MS
Associate Director, Research Planning & Development
MD Anderson Cancer Center
Faculty, Other Planning Committee Member
Nothing to disclose
Mary Dev, MSW, LCSW
Social Work Counselor
M D Anderson Cancer Center
Faculty, Other Planning Committee Member
Nothing to disclose
Erin Grannan, PharmD, BCOP
Clinical Pharmacy Specialist
University of Texas MD Anderson Cancer Center
Faculty, Other Planning Committee Member
Nothing to disclose
Virginia Kirklin, MPH
Program Manager, Advanced Breast Cancer Program
MD Anderson Cancer Center
Faculty, Other Planning Committee Member
Nothing to disclose
Marian Taylor, DNP, RN, CMSRN
Continuing Education Specialist
MD Anderson Cancer Center
Nurse Planner
Nothing to disclose
Alexandra Frenzel, BA-Sociology
Patient Advocate
Other Planning Committee Member
Nothing to disclose
Nicholas Navin, PhD
Dr.
MD Anderson Cancer Center
Other Planning Committee Member
Nothing to disclose
Debasish Tripathy, MD
Professor
MD Anderson Cancer Center
Other Planning Committee Member
Grant or research support-Novartis Pharmaceuticals Corporation|Consulting Fee-GlaxoSmithKline (Relationship has ended)|Consulting Fee-Gilead Sciences, Inc.|Consulting Fee-Novartis Pharmaceuticals Corporation|Consulting Fee-Pfizer Inc.|Consulting Fee-Personalis (Relationship has ended)|Consulting Fee-Sermonix (Relationship has ended)|Consulting Fee-Stemline-Menarini|Consulting Fee-Puma Biotechnology (Relationship has ended)|Consulting Fee-Roche (Relationship has ended)
Ashton M Underbrink, MPAS, PA-C
Physician Assistant- Certified
MD Anderson Cancer Center
Other Planning Committee Member
Nothing to disclose
Adam Widman, MD
Assistant Attending Physician
Memorial Sloan Kettering Cancer Center
Other Planning Committee Member
Nothing to disclose

Friday, February 28, 2025
Check-In / Breakfast (AGENDA IS SET IN THE CENTRAL TIME ZONE)
7:30AM - 8:20AM

Welcome and Conference Goals
8:20AM - 8:30AM
Bora Lim, MD

How to Pick the Right Dose?
8:30AM - 9:20AM
Julia Maués

Pathological Insight of Rare Breast Cancers
9:20AM - 9:40AM
Aatish Thennavan, PhD

IBC – New Insights into TME
9:40AM - 10:00AM
Bora Lim, MD

AM Networking/Coffee Break
10:00AM - 10:20AM

Updates on Management of ILC
10:20AM - 10:40AM
Jason A Mouabbi, MD

Mutation Targeted Medication and Special Challenges in Prescribing Them
10:40AM - 11:00AM
Erin Grannan, PharmD, BCOP

Patient Panel Discussion: The Goals of Care
11:00AM - 12:00PM
Mary Dev, MSW, LCSW
Rosemary Herron
Bora Lim, MD
Victoria McClosky, BSN
Wang Shein, BS

Noon - 1:00 PM Lunch with Advocates: Panel Discussion (No CE Credit Awarded)
12:00PM - 1:00PM

5 Pillars of Prehab in ABC
1:00PM - 1:20PM
Alice L Hughes, MPAS

Updates in TN-ABC Therapeutics
1:20PM - 1:40PM
Oluchi Oke, MD

Updates in HER2+ ABC Therapeutics
1:40PM - 2:00PM
Giancarlo Moscol, MD

PM Networking/Coffee Break
2:00PM - 2:20PM

TGF-ß and the Tumor Microenvironment: A Key Regulator of Cancer Progression
2:20PM - 2:40PM
Hila Shaim, MD

Stromal Barriers to Adoptive Cell Therapy in Solid Tumors
2:40PM - 3:00PM
Ranjan Upadhyay, MD, PhD

NK-Cell based CAR Therapy: Current Status and Future Directions
3:00PM - 3:20PM
Hind Rafei, MD MS

Panel Discussion
3:20PM - 3:40PM

PM Networking/Coffee Break
3:40PM - 4:00PM

RNA Methylation in Breast Cancer Gene Control and Therapeutic Targeting
4:00PM - 4:20PM
Wenbo Li, PhD

Liquid Tumor Evolution During Radiation
4:20PM - 4:40PM
Chelain Goodman, MD, PhD

New Paradigm to Monitor ctDNA During Neoadjuvant Therapy
4:40PM - 5:00PM
Taiwo Adesoye, MD

Welcome Reception
5:00PM - 6:30PM


All Participants, Faculty, Advocates and Exhibitors included
Saturday, March 1, 2025
Check-In / Breakfast (Agenda is set in the Central Time Zone)
7:30AM - 8:20AM

Welcome and Conference Goals
8:20AM - 8:30AM
Bora Lim, MD

Advancing Bone-Targeting Therapies and Harnessing Sequence Display-Enabled Machine Learning for Protein Evolution
8:30AM - 9:20AM
Han Xiao, PhD

Radiation Approaches in ABC – What Are We Missing?
9:20AM - 9:40AM
Melissa Mitchell, MD, PhD

Rewiring Neural Network Using Psilocybin
9:40AM - 10:00AM
Moran Amit, MD, PhD

Morning Networking/Coffee Break
10:00AM - 10:20AM

New BOIN Designs – What Does Future Hold on Finding the Right Dose?
10:20AM - 10:40AM
Ying Yuan, PhD

Modulation Liver Metastasis Using AAV
10:40AM - 11:00AM
Isaac Chan, MD, PhD

Developing Predictive Biomarker, TmS
11:00AM - 11:20AM
Yaoyi Dai, MS

Interaction of Energy Balance and Anti-Tumor Immunity
11:20AM - 11:40AM
Jasmine Sukumar, MD

Genomic Factors Related to Immunotherapy Toxicities
11:40AM - 12:00PM
chunru lin, PhD

Adjournment
12:00PM - 12:01PM

Platinum Level

Click Here to Visit Novartis' Site

Gold Level

Click Here to Visit Daiichi-Sankyo Inc.'s Website

Click Here to Visit Menarini Stemline's Website

Silver Level

Exact Sciences

IBC Network Foundation

Natera, Inc.

Bronze Level

AstraZeneca Pharmaceuticals

Eli Lilly and Company

GE Healthcare

Gilead Sciences, Inc.

Merck

Puma Biotechnology


Contact Us:
Robyn P. Davis, MPH, Senior Continuing Education Coordinator, Continuing Education
Continuing Professional Education – Unit 1781
The University of Texas MD Anderson Cancer Center
PO Box 301407
Houston, TX 77230-1407
Phone: 346-721-9712
Email: [email protected]


W9 Form Exhibit at this Event

Exhibitor Packages

Exhibitor Package - Bronze Level Price: $2500.00
Includes:
  • Recognition as a Bronze Level Exhibitor
  • 6ft. Tabletop Display (Draped) with Two Chairs
  • Number of Exhibitor Badges: 2
  • Complimentary meals (available with exhibitor badge)
  • Exhibit Location: Designated Location

Deadline for order commitment is 2/25/2025 12:00:00 AM.

Exhibitor Package - Silver Level Price: $5000.00
Includes:
  • Recognition as a Silver Level Exhibitor
  • 6ft. Tabletop Display (Draped) with Two Chairs
  • Number of Exhibitor Badges: 3
  • Complimentary meals (available with exhibitor badge)
  • Exhibit Location: Designated Location

Deadline for order commitment is 2/21/2025 12:00:00 AM.

Exhibitor Package - Gold Level Price: $7500.00
Includes:
  • Recognition as a Gold Level Exhibitor
  • 6ft. Tabletop Display (Draped) with Two Chairs
  • Number of Exhibitor Badges: 4
  • Complimentary meals (available with exhibitor badge)
  • Exhibit Location: Designated Premium Location

Deadline for order commitment is 2/21/2025 12:00:00 AM.

Exhibitor Package - Platinum Level Price: $10000.00
Includes:
  • Recognition as a Platinum Exhibitor
  • 6ft. Tabletop Display (Draped) with Two Chairs
  • Number of Exhibitor Badges: 5
  • Complimentary meals (available with exhibitor badge)
  • Exhibit Location: Designated Premium Location

Deadline for order commitment is 2/21/2025 12:00:00 AM.

Exhibitor Package - Additional Badge Price: $500.00
Includes:
  • Recognition as a Additional Badge Exhibitor
  • Number of Exhibitor Badges: 1

Deadline for order commitment is 2/28/2025 12:00:00 PM.

The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd.
Houston, TX 77030
 Privacy policies   

©2023 The University of Texas MD Anderson Cancer Center
Contact Us: [email protected]

See us on Facebook See us on Twitter See us on Linked In See us on Instagram